Inhalation drugs

Bronchodilators and anti-asthma drugs

Measured dose oral inhalation spray

While dilating the airways, this product reduces inflammation in the airways at the same time.

It is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

There are insufficient controlled studies of the combined use of budesonide and formitrol in pregnant women, and this product should only be taken during pregnancy when its benefit to the mother is justified compared to the risk to the fetus. This product is in the classification of drugs for use during pregnancy in group C. The diffusion of budesonide and formerol in breastfeeding mothers' milk has not been studied. This product should be used with caution in breastfeeding mothers.

1. During treatment with this product, it is better to check the usefulness and possible side effects of the drug during regular visits.
2. It is not used to relieve acute asthma attacks. For this purpose, fast-acting beta2-agonists are used.
3. This product should not be used as an initial treatment in patients with asthma, and if the patient does not respond to other asthma control drugs, this product should be used.
4. Patients should be advised to use this product continuously as long as the treating physician wishes.
5. It is recommended to rinse your mouth and gargle with water after each time you take the medicine, but rinse water should not be swallowed.
6. If you miss a dose of medicine. Take it as soon as you remember. Then use the remaining doses at regular medication intervals. Never double the dose
7. Long-term use of budesonide may cause growth retardation. The safety and effectiveness of this product has not been proven in children with asthma under 4 years of age
8. Bacterial, viral infections (chickenpox and measles) and Candida may worsen with this medicine.
9. Concomitant use of non-specific beta-blockers (propranolol) may reduce the effect of formiterol in the airways.
10. The simultaneous use of this product and ritonavir increases the blood concentration of budesonide and therefore decreases the concentration of hydrocortisone in the blood.
11. Ketoconazole increased oral budesonide blood concentration by inhibiting cytochrome P450.
12. In patients treated with MAO inhibitors (e.g., phenelzine), this product should either be taken with caution or two weeks after discontinuation of these medications, as the effect of formoterol on the vascular system can be exacerbated.

Side effects of this product can include heart palpitations and inflammation of the nasopharyngea, Paradoxical bronchospasm (contrary to expectation) cataract. Eosinophilia, allergic reactions. Increased intraocular pressure, glaucoma, skin rashes, and hives.

The dose of the drug in adults and children over the age of 12 is 2 puffs, twice a day (12 hours apart).

• Keep the medicine out of the reach of children.
• •Avoid taking expired medication or storing it for longer than needed.
• Before the patient starts taking the medicine, the medicine should be stored in the refrigerator at a temperature of 2 to 8 degrees Celsius. After the patient starts taking the medicine, store it at a temperature of 20 to 25 degrees Celsius, away from direct sunlight and moisture.
• Avoid freezing the inhaler and keeping it at a low temperature, if the container is cold at the time of use, the effectiveness of the medicine will decrease.
• Because the medicine container is full of gas and under pressure, avoid hitting it, piercing it or burning it, even if the container is empty.